Home › Employers › Abbvie Endocrinology Inc.
Abbvie Endocrinology Inc.: H-1B salaries and sponsorship
Abbvie Endocrinology Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $159,000.
Does Abbvie Endocrinology Inc. sponsor H-1B visas?
Abbvie Endocrinology Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Sep 8, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Senior Manager, IT Operations | 1 | $169,000 |
| Business System Consultant - Pharmacy Management Systems | 1 | $159,000 |
| Solution Architect | 1 | $155,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 1 | $169,000 |
| FY2025 | 2 | $157,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Solution Architect | $155,000–$175,000 Level IV | North Chicago, IL | Sep 8, 2025 | Sep 17, 2025 | Certified |
| Business System Consultant - Pharmacy Management Systems | $159,000–$179,000 Level IV | North Chicago, IL | Jan 2, 2025 | Jan 10, 2025 | Certified |
| Senior Manager, IT Operations | $169,000–$189,000 Level III | North Chicago, IL | Apr 5, 2024 | Apr 16, 2024 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).